FDA chief moves to promote artificial intelligence in health care

The Hill: The Food and Drug Administration is moving to encourage the use of artificial intelligence in health care, the agency’s chief said Thursday.

“AI holds enormous promise for the future of medicine,” FDA Commissioner Scott Gottlieb said in prepared remarks to the Health Datapalooza conference in Washington.

He said the FDA is working on an updated “new regulatory framework” that will allow regulators to keep up with new technology and “promote innovation in this space.”

Read article

Share